Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis

Nora Semren; Nunja C. Habel-Ungewitter; Isis E. Fernandez; Melanie Königshoff; Oliver Eickelberg; Tobias Stöger; Silke Meiners

doi:10.1371/journal.pone.0136188

Loading metrics

Open Access

Peer-reviewed

Research Article

Validation of the 2^nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis

Nora Semren,

Affiliation Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
⨯
Nunja C. Habel-Ungewitter,

Affiliation Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
⨯
Isis E. Fernandez,

Affiliation Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
⨯
Melanie Königshoff,

Affiliation Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
⨯
Oliver Eickelberg,

Affiliation Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
⨯
Tobias Stöger,

Affiliation Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
⨯
Silke Meiners

* E-mail: silke.meiners@helmholtz-muenchen.de

Affiliation Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum München, Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
⨯

Validation of the 2^nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis

Nora Semren,
Nunja C. Habel-Ungewitter,
Isis E. Fernandez,
Melanie Königshoff,
Oliver Eickelberg,
Tobias Stöger,
Silke Meiners

Published: September 4, 2015
https://doi.org/10.1371/journal.pone.0136188

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Proteasomes
Is the Subject Area "Proteasomes" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Fibroblasts
Is the Subject Area "Fibroblasts" applicable to this article?

Thanks for your feedback.
Proteasome inhibitors
Is the Subject Area "Proteasome inhibitors" applicable to this article?

Thanks for your feedback.
Pulmonary fibrosis
Is the Subject Area "Pulmonary fibrosis" applicable to this article?

Thanks for your feedback.
Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.
Luciferase
Is the Subject Area "Luciferase" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.